Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1954 1
1955 1
1957 1
1959 1
1960 2
1961 2
1962 2
1963 2
1964 1
1965 2
1966 3
1967 1
1968 6
1969 4
1970 2
1971 4
1972 7
1973 4
1974 4
1975 5
1976 9
1977 6
1978 9
1979 4
1980 8
1981 8
1982 8
1983 10
1984 5
1985 12
1986 12
1987 9
1988 13
1989 14
1990 4
1991 9
1992 9
1993 8
1994 11
1995 18
1996 5
1997 12
1998 18
1999 13
2000 18
2001 16
2002 18
2003 19
2004 20
2005 21
2006 22
2007 15
2008 24
2009 19
2010 38
2011 29
2012 31
2013 40
2014 54
2015 35
2016 32
2017 39
2018 43
2019 53
2020 65
2021 68
2022 55
2023 45
2024 37

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,034 results

Results by year

Filters applied: . Clear all
Page 1
Epilepsy and psychosis: a practical approach.
Maguire M, Singh J, Marson A. Maguire M, et al. Pract Neurol. 2018 Apr;18(2):106-114. doi: 10.1136/practneurol-2017-001775. Epub 2017 Dec 22. Pract Neurol. 2018. PMID: 29273616 Review.
Reply.
Maguire MG; CATT Research Group. Maguire MG, et al. Ophthalmology. 2017 Mar;124(3):e33. doi: 10.1016/j.ophtha.2016.06.046. Ophthalmology. 2017. PMID: 28219518 No abstract available.
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
CATT Research Group; Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. CATT Research Group, et al. Among authors: maguire mg. N Engl J Med. 2011 May 19;364(20):1897-908. doi: 10.1056/NEJMoa1102673. Epub 2011 Apr 28. N Engl J Med. 2011. PMID: 21526923 Free PMC article. Clinical Trial.
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. Among authors: maguire mg. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
Safety and efficacy of gene transfer for Leber's congenital amaurosis.
Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell'Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J. Maguire AM, et al. Among authors: maguire mg. N Engl J Med. 2008 May 22;358(21):2240-8. doi: 10.1056/NEJMoa0802315. Epub 2008 Apr 27. N Engl J Med. 2008. PMID: 18441370 Free PMC article. Clinical Trial.
Epilepsy.
Marson AG, Maguire M, Ramaratnam S. Marson AG, et al. Among authors: maguire m. BMJ Clin Evid. 2009 Jan 28;2009:1201. BMJ Clin Evid. 2009. PMID: 19445769 Review.
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: maguire m. Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4. Lancet. 2021. PMID: 33838758 Free PMC article. Clinical Trial.
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: maguire m. Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6. Lancet. 2021. PMID: 33838757 Free PMC article. Clinical Trial.
1,034 results